Get started
Author

Esra Aşık

Observed names: Esra Asik, Esra Asık, Esra Aşik
ORCID: 0000-0003-3030-2475
Observed ORCID: 0000-0003-3030-2475
OpenAlex ID: A5107543516
Effect of Ki-67 proliferation index on survival in large cell neuroendocrine carcinoma of the lung
2024 · Mustafa Emre Duygulu, Esra Aşık, et al. · Revista da Associação Médica Brasileira · 4
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
2025 · Salih Tunbekici, Gokhan Sahin, et al. · International Journal of Cancer · 3
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis
2026 · Baris Koksal, Hasan Cagri Yildirim, et al. · Journal of Clinical Medicine · 2
PDF
Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
2025 · Gökhan Şahin, Esmanur Kaplan Tüzün, et al. · International Journal of Cancer · 2
Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
2025 · Neslihan Özyurt, Ali Alkan, et al. · Scientific Reports · 1
Meme Kanseri Patolojisi
2026 · Esra Aşık · Akademisyen Kitabevi eBooks
Meme Cerrahisi
2026 · Büşra Ekici, Esra Özen Engin, et al. · Akademisyen Kitabevi eBooks
PDF
Resection and pathological response after neoadjuvant nivolumab plus chemotherapy for lung cancer in a Turkish Oncology Group (TOG) real-world study
2026 · Erdem Sünger, Bahadır Köylü, et al. · Research Square
PDF
Effects of tyrosine kinase inhibitors in treatment of non small cell lung cancer patients with brain metastases, real world experience
2026 · Mehmet Akif Tükenmez, Gamze Emin, et al. · Irish Journal of Medical Science (1971 -)
Clinicopathologic Features of NRG1 Fusion‐Positive Non‐Small Cell Lung Cancer
2026 · Bahadır Köylü, Nur İlayda Genç, et al. · Genes Chromosomes and Cancer
PDF
Prognostic impact of pathological complete response in hormone receptor–positive/HER2-negative breast cancer treated with neoadjuvant chemotherapy: a multicenter cohort study
2026 · Esma Uguztemur, Ozgur Arici, et al. · Scientific Reports
PDF
Demographic Characteristics, Clinical Features, and Treatment Patterns of Classic and AIDS-Related Kaposi Sarcoma: A Multicenter Real-World Study from Turkey
2026 · Ahmet Kürşad Dişli, Bekir Mert Durukan, et al. · Medicina
PDF
Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
2026 · Neslihan Özyurt, Ali Alkan, et al. · Cancers
PDF
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study
2026 · Suheda Atas Ipek, Sendag Yaslikaya, et al. · Journal of Clinical Medicine
PDF
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study
2026 · Bahadır Köylü, Özde Melisa Celayir, et al. · Cancers
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group
2026 · Sedat Yıldız, Hacer Demir, et al. · Journal of Clinical Medicine
PDF
Meme Kanseri
2026 · Semra Taş, Ali Alper Solmaz, et al. · Akademisyen Kitabevi eBooks
PDF
HER-2 Pozitif Meme Kanserinde Neoadjuvan Tedavi
2026 · Esra Aşık · Akademisyen Kitabevi eBooks
Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group study
2025 · Safa Can Efil, Burak Bilgin, et al. · Scientific Reports
PDF
Beslenmenin Çocuklarda Diş Çürüklerine Etkisinin Değerlendirilmesi
2015 · Gamze Aren, Ceren Güney Tolgay, et al. · Turkiye Klinikleri Pediatric Dentistry - Special Topics
Works count: 20
Citation count: 12
H-index: 2
I10-index:
Year
Topic
Type